Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03990233
Title A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors OSE Immunotherapeutics
Indications

ovarian cancer

colorectal cancer

stomach cancer

spinal cord lymphoma

melanoma

lung non-small cell carcinoma

triple-receptor negative breast cancer

renal cell carcinoma

pancreatic cancer

head and neck squamous cell carcinoma

transitional cell carcinoma

Advanced Solid Tumor

Therapies

Effi-DEM

Effi-DEM + Ezabenlimab

Age Groups: adult | senior
Covered Countries FRA | BEL

Facility Status City State Zip Country Details
Institut Jules Bordet Recruiting Brussels 1000 Belgium Details
Universitair Ziekenhuis Brussel Recruiting Brussel 1000 Belgium Details
Universitair Ziekenhuis Gent Recruiting Gent 9000 Belgium Details
Institut Bergonie Recruiting Bordeaux 33076 France Details
Centre Léon Berard Recruiting Lyon 69373 France Details
Institut Claudius Regaud Recruiting Toulouse 31059 France Details
Institut Gustave Roussy Recruiting Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field